av/marksans-pharma--big.svg

COM:MARKSANSPHARMA

Marksans Pharma

  • Stock

Last Close

288.60

12/11 09:59

Market Cap

87.17B

Beta: -

Volume Today

6.81M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
Mar '24
revenue
6.30B
-
7.97B
26.46%
8.93B
12.13%
7.67B
14.12%
9.13B
18.97%
9.87B
8.18%
11.29B
14.38%
13.68B
21.17%
14.80B
8.17%
18.52B
25.13%
21.77B
17.56%
cost of revenue
3.68B
-
4.45B
21.07%
5.10B
14.43%
4.72B
7.39%
5.48B
16.14%
5.17B
5.60%
5.68B
9.82%
6.19B
8.84%
7.48B
20.92%
9.21B
23.17%
14.06B
52.60%
gross profit
2.62B
-
3.51B
34.03%
3.84B
9.22%
2.95B
23.07%
3.65B
23.50%
4.70B
28.90%
5.61B
19.40%
7.50B
33.65%
7.32B
2.36%
9.31B
27.14%
7.71B
17.13%
selling and marketing expenses
99.13M
-
236.78M
138.86%
475.90M
100.98%
666.31M
40.01%
792.60M
18.95%
1.10B
38.29%
1.49B
36.35%
1.03B
31.39%
general and administrative expenses
214.54M
-
192.03M
10.49%
206.30M
7.43%
232.05M
12.48%
179.66M
22.58%
238.83M
32.94%
247.99M
3.84%
162.62M
34.42%
selling general and administrative expenses
313.67M
-
428.82M
36.71%
682.20M
59.09%
898.35M
31.69%
972.25M
8.23%
1.33B
37.30%
1.74B
30.53%
2.52B
44.66%
3.87B
53.55%
research and development expenses
57.13M
-
83.15M
45.55%
128.66M
54.74%
192.50M
49.62%
158.89M
17.46%
other expenses
1.60B
-
1.83B
14.16%
2.48B
35.80%
2.50B
0.75%
1.99M
99.92%
903.63K
54.65%
1.50M
66.24%
38.73M
2,478.44%
95.62M
146.87%
593.13M
520.30%
504.22M
14.99%
cost and expenses
5.28B
-
6.28B
18.97%
7.89B
25.64%
7.65B
3.08%
8.61B
12.60%
8.78B
1.96%
9.64B
9.75%
10.50B
8.93%
12.63B
20.36%
15.65B
23.85%
17.93B
14.60%
operating expenses
1.60B
-
1.83B
14.16%
2.79B
52.98%
2.93B
4.79%
3.13B
6.90%
3.61B
15.21%
3.95B
9.65%
4.31B
9.05%
5.15B
19.56%
6.43B
24.82%
3.87B
39.83%
interest expense
86.98M
-
62.94M
27.64%
39.61M
37.07%
64.94M
63.93%
59.25M
8.76%
49.70M
16.11%
34.68M
30.23%
53.90M
55.44%
91.28M
69.35%
112.03M
22.73%
ebitda
1.18B
-
1.81B
53.39%
1.41B
21.83%
495.59M
64.92%
831.35M
67.75%
1.33B
59.76%
1.89B
42.18%
3.54B
87.69%
2.95B
16.88%
3.99B
35.33%
4.59B
15.04%
operating income
864.11M
-
1.56B
80.40%
1.07B
31.46%
155.29M
85.47%
515.99M
232.27%
1.09B
111.89%
1.70B
55.70%
3.09B
81.64%
2.14B
30.76%
2.88B
34.39%
3.84B
33.56%
depreciation and amortization
156.91M
-
161.34M
2.82%
281.27M
74.33%
300.93M
6.99%
268.38M
10.82%
228.04M
15.03%
266.62M
16.92%
361.51M
35.59%
447.76M
23.86%
518.53M
15.81%
742.70M
43.23%
total other income expenses net
-157.09M
-
-127.69M
18.72%
25.56M
120.02%
131.04M
412.71%
-18.01M
113.74%
-50.28M
179.23%
-130.67M
159.87%
-70.56M
46.00%
334.07M
573.46%
499.21M
49.43%
392.19M
21.44%
income before tax
864.11M
-
1.56B
80.40%
1.07B
31.46%
155.29M
85.47%
497.98M
220.67%
1.04B
109.46%
1.57B
50.68%
3.02B
92.25%
2.48B
18.09%
3.38B
36.42%
4.24B
25.43%
income tax expense
127.87M
-
439.21M
243.48%
241.08M
45.11%
35.15M
85.42%
139.97M
298.22%
238.69M
70.53%
364.19M
52.58%
636.25M
74.70%
606.97M
4.60%
723.32M
19.17%
1.09B
50.18%
net income
719.08M
-
1.09B
52.13%
785.12M
28.23%
95.19M
87.88%
329.40M
246.05%
804.37M
144.19%
1.21B
50.12%
2.39B
97.54%
1.85B
22.62%
2.66B
44.29%
3.14B
17.80%
weighted average shs out
385.31M
-
409.31M
6.23%
409.31M
0%
409.31M
0%
409.31M
0%
409.31M
0%
409.31M
0%
409.31M
0.00%
409.31M
0%
415.40M
1.49%
453.32M
9.13%
weighted average shs out dil
385.31M
-
409.31M
6.23%
409.31M
0%
409.31M
0%
409.31M
0%
409.31M
0%
409.31M
0%
409.31M
0.00%
409.31M
0%
415.40M
1.49%
453.32M
9.13%
eps
1.87
-
2.67
42.78%
1.92
28.09%
0.22
88.54%
0.80
263.64%
1.97
146.25%
2.86
45.18%
5.76
101.40%
4.51
21.70%
6.41
42.13%
6.92
7.96%
epsdiluted
1.87
-
2.67
42.78%
1.92
28.09%
0.22
88.54%
0.80
263.64%
1.97
146.25%
2.86
45.18%
5.76
101.40%
4.51
21.70%
6.41
42.13%
6.92
7.96%

All numbers in (except ratios and percentages)